Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male Volunteers-Reference-Cited by-同舟云学术

Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male Volunteers

Published:2021-09 Issue:9 Volume:43 Page:e264-e273
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Chen Zhen-dong,Chen Qian,Zhu Yun-ting,Zhang Yi-fan,Zhan Yan,Chen Xiao-fei,liang Xin,Jia Jing-ying,Yu Chen,Liu Hai-yan,Zou Jian-jun,Liu Yan-mei,Zhong Da-fang

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference19 articles.

1. SGLT2 inhibition—a novel strategy for diabetes treatment;Chao;Nat Rev Drug Discov,2010

2. SGLT2 inhibition and kidney protection;Nespoux;Clin Sci (Lond),2018

3. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology;Seferović;Eur J Heart Fail,2018

4. Suitability of APINCH high-risk medications use in diabetes mellitus;Zafar;Eur J Pharmacol,2020

5. Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes;Abdul-Ghani;Endocr Rev,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Drug-Drug Interaction Between Henagliflozin and Hydrochlorothiazide in Healthy Chinese Volunteers;Drug Design, Development and Therapy;2024-05

2. Pharmacokinetic and Pharmacodynamic Interactions Between Henagliflozin, a Novel Selective SGLT-2 Inhibitor, and Warfarin in Healthy Chinese Subjects;Clinical Therapeutics;2023-07

3. Design, conduct, and interpretation of human mass balance studies and strategies for assessing metabolites-in-safety testing (MIST) in drug development;Overcoming Obstacles in Drug Discovery and Development;2023

4. Effects of Food and Multiple‐dose Administration on the Pharmacokinetic Properties of HR20033, a Sustained‐release Formulation of Henagliflozin and Metformin for the Treatment of Diabetes, in Healthy Chinese Volunteers;Clinical Pharmacology in Drug Development;2022-11-21